Skip to content

The Effect of Nursing Care With Peri-Natal Loss

The Effect of Standardised Nursing Care Given to Women With Peri-Natal Loss on Peri-Natal Grief, Posttraumatic Stress, Postpartum Depression

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06896214
Enrollment
58
Registered
2025-03-26
Start date
2025-04-15
Completion date
2025-12-30
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal Grief, Perinatal Loss

Keywords

perinatal grief, perinatal loss,, Postpartum Depression, post-traumatic stress disorder

Brief summary

This study was planned to evaluate the effect of standardised nursing care given to women with perinatal loss using the nursing process on perinatal grief, posttraumatic stress and postpartum depression. H01: There is no difference between pre-test, post-test and follow-up tests in terms of perinatal grief scale mean scores in the intervention group. H02: There is no difference between pre-test, post-test and follow-up tests in terms of IES-R mean scores in the intervention group. H03: There is no difference between pre-test, post-test and follow-up tests in terms of EPDS mean scores in the intervention group. H04: There is no difference between the pre-test post-test and follow-up tests in terms of the mean scores of the Complicated Grief Scale in the intervention group. * At the first encounter with women, the mean scores of PMI, IESR and EPDS will be evaluated. * The mean EPDS score will be evaluated on the 10th postpartum day, 1st, 3rd and 6th month. * The mean I-ESR scale score will be evaluated at postpartum 1st, 3rd and 6th month. * At postpartum 1st and 3rd month, the mean score of PMS will be evaluated. * At the postpartum 6th month, the mean score of the PBI scale will be evaluated.

Interventions

OTHERStandardised nursing care intervention

Standardised nursing care intervention

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

In this study, two of the researchers will carry out the application and the other researchers will be blinded. However, participant blinding will not be possible.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

- To be over 18 years old * Being married (according to the woman's declaration) * Not having an existing psychiatric illness (according to the woman's declaration) * Not having communication problems (knowing Turkish, being literate, not having vision, speech or hearing problems, etc.) * Spontaneous conception * Singleton pregnancy * No substance addiction

Exclusion criteria

Women who agreed to participate in the study but did not want to receive post-discharge care, who were hospitalised for any reason, who became pregnant again, who did not want to complete the last tests or who wanted to leave the study at any stage of the study will be excluded from the sample.

Design outcomes

Primary

MeasureTime frameDescription
Peritanal grief scaleat the 1st and 3rd postpartum months. The perinatal grief scale is scored between 32-160\- The mean PGS score will be evaluated at the 1st and 3rd postpartum months.
Edinburgh Postpartum depression scalePostpartum day 10, 1, 3 and 6 month. The Edinburgh Postpartum Depression Scale is scored between 0 and 30.\- The mean EPDS score will be evaluated at postpartum day 10, 1, 3 and 6 months.
Impact of Events Scale-revisedPostpartum 1, 3 and 6 months. The Impact of Events Scale is scored between 0 and 88.\- The mean IESR score will be evaluated at 1, 3 and 6 months.
Complicated grief scaleAt the 6th postpartum month.The Complicated Grief Scale is scored between 0 and 55. As the score increases, the severity of grief increases.At the 6th postpartum month, the mean score of the CGS will be evaluated.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026